文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

SYVN1促进STAT3蛋白泛素化并在早产儿视网膜病变发展中发挥抗血管生成作用

SYVN1 Promotes STAT3 Protein Ubiquitination and Exerts Antiangiogenesis Effects in Retinopathy of Prematurity Development.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2023-01-01

本研究利用人视网膜微血管内皮细胞(hRMECs)和氧诱导视网膜病变(OIR)小鼠模型,探讨SYVN1在早产儿视网膜病变(ROP)中的作用。结果显示缺氧和ROP小鼠视网膜中SYVN1表达下降,SYVN1过表达通过促进STAT3泛素化降解、下调VEGF来抑制新生血管形成,且不影响视网膜功能。作者认为SYVN1可能是增殖性视网膜病变的潜在新药靶点。

要点

  • 缺氧hRMECs和ROP小鼠视网膜中内源性SYVN1表达显著下降。
  • SYVN1过表达促进STAT3泛素化降解,降低p-STAT3和VEGF分泌,抑制hRMECs新生血管形成。
  • OIR小鼠玻璃体腔注射SYVN1过表达腺病毒可抑制新生血管并延长生理性视网膜血管发育,不影响视网膜功能。

核心结论

  • SYVN1对OIR具有保护作用,其分子机制部分通过SYVN1介导的STAT3泛素化及后续VEGF下调实现。
  • 作者认为这些发现强烈支持SYVN1赋予ROP抵抗性的假设,并可能成为抗增殖性视网膜病变的潜在新药靶点。

研究设计与样本

  • 研究使用人视网膜微血管内皮细胞(hRMECs)和氧诱导视网膜病变(OIR)小鼠模型。
  • 于出生后第12天(P12)玻璃体腔注射过表达SYVN1的腺病毒或载体对照,P17通过视网膜铺片免疫荧光染色和HE染色评估新生血管病变。
  • 通过视网膜电图(ERG)评估视觉功能。

主要发现

  • 缺氧hRMECs和ROP小鼠视网膜中内源性SYVN1表达显著下降。
  • SYVN1调控STAT3/VEGF轴;SYVN1过表达促进STAT3泛素化和降解,降低p-STAT3水平、VEGF分泌及hRMECs新生血管形成,STAT3激活剂处理可逆转上述效应。
  • OIR小鼠中SYVN1过表达抑制新生血管并延长生理性视网膜血管发育,且不影响视网膜功能。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: SYVN1, a gene involved in endoplasmic reticulum-associated degradation, has been found to exert a protective effect by inhibiting inflammation in retinopathy. This study aimed to clarify whether SYVN1 is involved in the pathogenesis of retinopathy of prematurity (ROP) and its potential as a candidate for target therapy. METHODS: Human retinal microvascular endothelial cells (hRMECs) and a mouse model of oxygen-induced retinopathy (OIR) were used to reveal the retinopathy development-associated protein expression and molecular mechanism. An adenovirus overexpressing SYVN1 or vehicle control was injected intravitreally at postnatal day 12 (P12), and the neovascular lesions were evaluated in retinal flatmounts with immunofluorescence staining, and hematoxylin and eosin staining at P17. Visual function was assessed by using electroretinogram (ERG). RESULTS: Endogenous SYVN1 expression dramatically decreased in hRMECs under hypoxia and in ROP mouse retinas. SYVN1 regulated the signal transducer and activator of transcription 3 (STAT3)/vascular endothelial growth factor (VEGF) axis. SYVN1 overexpression promoted ubiquitination and degradation of STAT3, decreased the levels of phospho-STAT3, secretion of VEGF, and formation of neovascularization in hRMECs, which could be rescued by STAT3 activator treatment. In addition, SYVN1 overexpression prevented neovascularization and extended physiologic retinal vascular development in the retinal tissues of OIR mice without affecting retinal function. CONCLUSIONS: SYVN1 has a protective effect against OIR, and the molecular mechanisms are partly through SYVN1-mediated ubiquitination of STAT3 and the subsequent downregulation of VEGF. These findings strongly support our assumption that SYVN1 confers ROP resistance and may be a potentially novel pharmaceutical target against proliferative retinopathy.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Chen S, Zhang J, Sun D, et al. SYVN1 Promotes STAT3 Protein Ubiquitination and Exerts Antiangiogenesis Effects in Retinopathy of Prematurity Development. Invest Ophthalmol Vis Sci. 2023. PMID: 37540175. doi:10.1167/iovs.64.11.8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。